DISASTERS AVERTED — Near Miss Case Studies
Prevent Infection Transmission During Assisted Glucose Monitoring
TOP STORIES — Diabetes News and Research
ADA 81st Symposium: Tirzepatide a Novel GIP/GLP-1 Agonist-Current Update
Can HbA1c Variability Predict Diabetic Complications?
Oily Fish Lower Risk of Diabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Low-Calorie Mediterranean Diet vs. Low Carb Diet for Weight Loss
#2 Key Exercises and Training for Aging Successfully and Living Your Best Life
#3 Benefits for Patients with Type 1 Diabetes Using the New Omnipod® 5
Letter from the Editor
One of the benefits of the shift to virtual conferences is that more people can attend and only have to carve out time for what their interests are. This past week the ADA Scientific Sessions were virtual, and that gave us a chance to have our PharmD interns attend and get firsthand knowledge on the latest in diabetes care. We will be featuring their articles over the next few weeks.
This week, we start out with a feature by Jasmine Dumontier-Hiott, PharmD Candidate, USF College of Pharmacy, looking at research on the newest diabetes combo, a GLP-1 agonist and a GIP agonist. The study was presented by Dr. Drucker and Dr. Frias, among others, and Jasmine delivers the meat of the presentation for you to review.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
DISASTERS AVERTED — Near Miss Case Studies
Several warnings have been issued by the CDC regarding unsafe practices that might result in the transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other infectious diseases during assisted blood glucose monitoring and insulin administration.
TOP STORIES — Diabetes News and Research
Results for SURPASS-1 and SURPASS-2 trials of tirzepatide in patients with type 2 diabetes inadequately controlled with diet and exercise alone were presented at this year’s virtual symposium. If you weren’t able to attend the symposium, you can read about the trials here.
A study was conducted to assess if HbA1c variability impacts the incidence of diabetic complications, all-cause and cardiovascular mortality.
People who reported two or more servings per week of oily fish consumption had a 22% lower risk of developing type 2 diabetes.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
